Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.
Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.
Trevi Therapeutics的股票在公司公佈對慢性咳嗽II期CORAL試驗患者治療的積極結果後上漲。
Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.
Trevi Therapeutics的股票在公司公佈對慢性咳嗽II期CORAL試驗患者治療的積極結果後上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。